Uncoated Tablet with Coating Layer for Disintegration and Photostability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing tablets comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one (Compound (I)) or its salt lack excellent disintegration ability, storage stability, and photostability.

Innovation Solution

A tablet formulation comprising Compound (I) or its salt, lactose, corn starch, microcrystalline cellulose, low-substituted hydroxypropyl cellulose, hydroxypropyl cellulose, and magnesium stearate, with a coating layer containing a colorant like iron oxide, to enhance disintegration, storage, and photostability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If a tablet formulation is designed to improve disintegration ability, then disintegration performance is improved, but storage stability and photostability may deteriorate

Engineering Contradiction:
Improvedisintegration abilityVSAvoidstorage stability and photostability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent divides the tablet into distinct functional layers: a core layer containing the active ingredient and disintegrant for disintegration ability, and a coating layer containing colorant and stabilizing agents for storage and photostability. This segmentation allows each layer to optimize its specific function without compromising the other properties.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The tablet uses a composite formulation combining multiple materials with complementary properties: low-substituted hydroxypropyl cellulose provides both disintegration capability and stability, while the coating layer incorporates colorants and stabilizing agents that enhance photostability without affecting the core's disintegration performance.

Inventive Principle:
Principle #40Composite materials

2Stability of the object's composition

If excipients and coatings are added to improve storage and photostability, then stability is improved, but disintegration ability may worsen

Engineering Contradiction:
Improvestorage stability and photostabilityVSAvoiddisintegration ability
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent applies different properties to different parts of the tablet: the core layer has high disintegration ability with minimal stabilizing agents, while the coating layer has high stability and photostability. The coating is applied locally on the surface, allowing the core to disintegrate effectively while the coating provides protective functions.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent carefully controls the substitution degree of hydroxypropyl groups in the cellulose derivative (low-substituted, 1.5-3.0 moles per anhydroglucose unit) to balance disintegration and stability. The coating layer parameters are also optimized to provide protection without creating a barrier that would prevent disintegration.

Inventive Principle:
Principle #35Parameter changes

3Stability of the object's composition

If a coating layer with colorant is applied to enhance photostability, then photostability is improved, but device complexity increases

Engineering Contradiction:
ImprovephotostabilityVSAvoidtablet structure complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The coating layer serves multiple functions simultaneously: it provides photostability through colorant inclusion, offers a barrier against moisture and oxygen for enhanced storage stability, and maintains a smooth surface for controlled disintegration. This multi-functionality reduces the need for separate components for each function.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentEP2767285B2TABLET COMPRISING 7-[4-(4-BENZO[b]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF
Publication Date: 2025.02.19 OTSUKA PHARM CO LTD
  • EP2767285B2 patent drawingFigure 1

AI summary

This invention relates to a tablet containing, as an active ingredient, 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof, that has excellent disintegration ability, storage stability and photostability. The tablet of the present invention comprising an uncoated tablet containing 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof as an active ingredient, excipients such as lactose, corn starch, and microcrystalline cellulose; disintegrants such as low-substituted hydroxypropylcellulose, croscarmellose sodium, and sodium carboxymethyl starch; binders such as hydroxypropylcellulose; lubricants such as stearate; and further comprising a coating layer containing hypromellose; talc; titanium oxide; colorant; and the like, the coating layer being applied to the surface of the uncoated tablet.